Missouri Schools & Home State Health: Fostering Belonging on National No One Eats Alone® Day
Missouri Schools & Home State Health: Fostering Belonging on National No One Eats Alone® Day For the sixth consecutive year, Home State Health, a Managed Care Organization catering to Medicaid recipients in collaboration with MO HealthNet and a subsidiary of…
Wayne Mobile Health Unit Receives $1.1M Grant
Meridian in Michigan, a prominent managed care organization and subsidiary of Centene Corporation (NYSE: CNC), has teamed up with the Wayne Mobile Health Unit (WMHU) to enhance maternal and infant health. This partnership extends support to WMHU’s community outreach initiatives,…
Improving North Carolinians’ Health: WellCare & Reinvestment Partners Collaborate
Improving North Carolinians’ Health: WellCare & Reinvestment Partners Collaborate Today, WellCare of North Carolina, a subsidiary of Centene Corporation (NYSE: CNC), unveiled a strategic collaboration with Reinvestment Partners. This partnership aims to leverage the expertise of Reinvestment Partners, a non-profit…
Armis Recognized as Leading Performer in 2024 Best in KLAS Report for Healthcare IoT Security
Armis , the asset intelligence cybersecurity company, today announced it has been named “Top Performer” in the 2024 Best in KLAS Software & Services Report for Healthcare IoT Security for the second year in a row got. The Best in KLAS report recognizes software…
Revvity Signals Software Introduces Signals Clinical Solution for Expedited Clinical Trial Insights and Informed Data-Driven Decision-Making
Today, Revvity, Inc. (NYSE: RVTY) has unveiled the Signals ClinicalTM solution through its software and informatics division, Revvity Signals. This groundbreaking software-as-a-service (SaaS) platform is designed to revolutionize clinical trial data management, offering comprehensive insights to facilitate informed decision-making and…
Armis Achieves Top Ranking for IoT Security in Healthcare According to the 2024 KLAS Report
Armis, a leading cybersecurity company specializing in asset intelligence, proudly announces its recognition as a top performer in healthcare IoT security for the second consecutive year in the 2024 “Best in KLAS” Software & Services Report. This esteemed accolade underscores…
Repare Therapeutics Reacquires Global Rights to Camonsertib
Repare Therapeutics to Regain Global Rights to Camonsertib Following Collaboration Termination with Roche” Repare Therapeutics Inc. (Nasdaq: RPTX), a prominent clinical-stage precision oncology company, has announced its intention to reclaim global development and commercialization rights to camonsertib (RP-3500), a potential…
Otsuka Reveals Phase 3 Topline Findings for AVP-786 in Treating Agitation Linked to Alzheimer’s Disease Dementia
Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and its parent company, Otsuka Pharmaceutical Co., Ltd. (Otsuka), have disclosed the topline findings from the phase 3 clinical trial of AVP-786 aimed at treating agitation associated with dementia due to Alzheimer’s disease…
Medpace Holdings, Inc. Announces Financial Results for Q4 and Full Year 2023
Medpace Holdings, Inc. (Nasdaq: MEDP) has released its financial results for the fourth quarter and full year ending December 31, 2023. Fourth Quarter 2023 Financial Highlights: Full Year 2023 Financial Highlights: Balance Sheet and Liquidity: Source link
Baxter Announces Financial Results for Q4 and Full-Year 2023
Baxter International Inc. (NYSE:BAX), a leading global medtech company, has announced its financial results for the fourth quarter and full year ending Dec. 31, 2023, alongside providing financial guidance for full-year and first-quarter 2024. José (Joe) E. Almeida, Chair, President,…
Utilizing Fundamental Technology to Bridge the Gap in Cancer Care
Regardless of one’s identity, hearing the diagnosis “you have cancer” initiates a whirlwind of emotions, ranging from shock and disbelief to acceptance and determination. As clinicians, the moment we convey these words, patients yearn for comprehensive information to swiftly develop…
Cencora’s FormularyDecisions Introduces Payer Resource for Cell and Gene Therapy Products
Amidst the growing landscape of cell and gene therapy (CGT) products in clinical development, Cencora’s FormularyDecisions has unveiled a new resource tailored to offer healthcare payers centralized access to information on approved therapies and those in the pipeline. FormularyDecisions, a…